MedPath

treatment schizophrenia patients: double-blind randomized controlled trial

Not Applicable
Conditions
schizophrenia.
Schizophrenia
Registration Number
IRCT20210608051514N1
Lead Sponsor
Zanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
30
Inclusion Criteria

Having a diagnosis of schizophrenia
Having the ability to write informed consent
Experience positive symptoms despite a month of stabilization in medication dose
The same dose and medicine
Being a man
Being right-handed
Age 65_18 years
The dose of antipsychotic medication used by the person is constant at the beginning and during the research
Stabilization in drug treatment for at least 6 weeks

Exclusion Criteria

Have a history of suicide and abuse of alcohol and substances other than caffeine and tobacco in the past month
Have a history of neurological diseases such as Parkinson's, epilepsy, seizures, stroke and cardiovascular problems
Having diseases related to the scalp
Having a history of head trauma and the presence of a device or tool in the head
Withdrawal from the study after absence in two consecutive sessions of treatment.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
egative symptoms:Theoretical definition: It is one of the clinical symptoms in schizophrenia that includes superficial emotion, poor speech, lack of motivation, unhappiness and social transgression.Operational definition: The score that a person gets from the positive and negative symptoms of schizophrenia.Positive symptoms: Theoretical definition includes delusions, delusions, disturbed speech, and disturbed behavior that persist throughout a one-month period.Operational definition: The score that a person gets from the positive and negative symptoms of schizophrenia. Timepoint: Pre-test-post-test-one-month follow-up-quarterly follow-up. Method of measurement: The score that a person gets from the questionnaire for measuring positive and negative symptoms in schizophrenia.
Secondary Outcome Measures
NameTimeMethod
Working memory:Theoretical definition: means the ability to store and manipulate information in memory, which is an essential prerequisite for complex cognitive tasks such as learning, reasoning and comprehension. Timepoint: Pre-test-post-test-one-month follow-up-quarterly follow-up. Method of measurement: The score a person gets from the n back test.
© Copyright 2025. All Rights Reserved by MedPath